IE
NUVB icon

Israel Englander’s Nuvation Bio NUVB Stock Holding History

Israel Englander’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,600
Closed -$34.3K – 6389
2023
Q3 		$34.3K Buy
+25,600
New +$42.6K ﹤0.01% 5554

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Israel Englander's NUVB Position: Q2 2026 in Review

Israel Englander reduced its Nuvation Bio (NUVB) stake by 67% in Q2 2026, selling an estimated $3.66M and leaving 372,858 shares worth $2.12M. The position accounts for ﹤0.01% of the portfolio, ranked #3770.

Israel Englander first reported a position in NUVB in Q3 2020 and has held it in 21 quarters since. The position peaked at $18M in Q3 2025. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Israel Englander held 372,858 shares of Nuvation Bio worth $2.12M as of Q2 2026.
  • Israel Englander sold 749,322 Nuvation Bio shares in Q2 2026, an estimated $3.66M.
  • Nuvation Bio made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #3770 holding.
  • Israel Englander first reported a position in Nuvation Bio in Q3 2020 and has held it in 21 quarters since.
  • Israel Englander's Nuvation Bio position peaked at $18M in Q3 2025.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.